Approach to Vascular Access After Renal Transplantation
NCT ID: NCT04478968
Last Updated: 2020-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2020-01-03
2022-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiparametric MRI for Assessment of Changes of Renal Hemodynamics After Fistula Closure in Kidney Transplant Patients
NCT05015231
Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
NCT04842591
Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants
NCT01982903
A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury
NCT05179434
Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant
NCT01271465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* detailed clinical examination
* routine laboratory tests
* lung ultrasound
* muscle strength with a dynamometer
* ultrasound assessment of upper limb vessels with assessment of fistula function (in the case of active fistula) and for the possibility of future vascular access
* blood collection and protection (10-15 ml) for biomarkers
* survey EQ-5D-5L and LVD-36
* functional strength test.
The obtained clinical data and test results will be subject to statistical analysis after anonymization. The impact of individual parameters on long-term prognosis will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active AVF
Patients after kidney transplantation with functioning AVF
presence of AVF
Functioning AVF may have cardiotoxic potential
No AVF
Patients after kidney transplantation without AVF (thrombosed AVF, history of HD with catheter, history of PD, preemptive transplantation)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
presence of AVF
Functioning AVF may have cardiotoxic potential
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* kidney transplant
* \>12 months after transplantation
* stable transplanted kidney function
* signed informed consent
Exclusion Criteria
* severe infection within 3 months of testing
* increase in creatinine concentration\> 0.5 mg / dl within 3 months before the test
* active cancer
* signs of severe heart failure (NYHA IV)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wroclaw Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Krzysztof Letachowicz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nephrology and Transplantation Medicine
Wroclaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MINI.C160.20.001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.